# TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

> **NCT07460960** · PHASE2 · RECRUITING · sponsor: **Lomonosov Moscow State University Medical Research and Educational Center** · enrollment: 150 (estimated)

## Conditions studied

- Erectile Dysfunction Due to Arterial Disease
- Atheroscleroses
- Erectile Disfunction
- Endothelial Dysfunction
- Androgen Profile
- Testosterone

## Interventions

- **DRUG:** Pitavastatin 1-4 mg daily
- **DRUG:** Rosuvastatin 20-40 mg daily

## Key facts

- **NCT ID:** NCT07460960
- **Lead sponsor:** Lomonosov Moscow State University Medical Research and Educational Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-05
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- Nizhpharm

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07460960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07460960, "TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07460960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*